Sign in
Explore the registryTrack Lebrikizumab's trials

A Study of Lebrikizumab (LY3650150) With/Without Topical Corticosteroid Treatment in Participants With Moderate-to-Severe Atopic Dermatitis

LebrikizumabOngoingActive not recruitingPhase 3Open NCT06280716 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…